HEADER MEMBRANE PROTEIN 11-OCT-22 8ERC TITLE HUMAN MEMBRANE-BOUND O-ACYLTRANSFERASE 7 COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYSOPHOSPHOLIPID ACYLTRANSFERASE 7; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: LPLAT 7,1-ACYLGLYCEROPHOSPHATIDYLINOSITOL O-ACYLTRANSFERASE, COMPND 5 BLADDER AND BREAST CARCINOMA-OVEREXPRESSED GENE 1 PROTEIN,LEUKOCYTE COMPND 6 RECEPTOR CLUSTER MEMBER 4,LYSOPHOSPHATIDYLINOSITOL ACYLTRANSFERASE, COMPND 7 LPIAT,LYSO-PI ACYLTRANSFERASE,MEMBRANE-BOUND O-ACYLTRANSFERASE COMPND 8 DOMAIN-CONTAINING PROTEIN 7,O-ACYLTRANSFERASE DOMAIN-CONTAINING COMPND 9 PROTEIN 7,H-MBOA-7; COMPND 10 EC: 2.3.1.-; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MBOAT7, BB1, LENG4, OACT7; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS LIPID METABOLISM MEMBRANE REMODELING, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR K.WANG,M.LIAO,R.V.FARESE,T.C.WALTHER REVDAT 1 27-SEP-23 8ERC 0 JRNL AUTH K.WANG,C.W.LEE,X.SUI,S.KIM,S.WANG,A.B.HIGGS,A.J.BAUBLIS, JRNL AUTH 2 G.A.VOTH,M.LIAO,T.C.WALTHER,R.V.FARESE JR. JRNL TITL THE STRUCTURE OF PHOSPHATIDYLINOSITOL REMODELING MBOAT7 JRNL TITL 2 REVEALS ITS CATALYTIC MECHANISM AND ENABLES INHIBITOR JRNL TITL 3 IDENTIFICATION. JRNL REF NAT COMMUN V. 14 3533 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 37316513 JRNL DOI 10.1038/S41467-023-38932-5 REMARK 2 REMARK 2 RESOLUTION. 3.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.700 REMARK 3 NUMBER OF PARTICLES : 206418 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8ERC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1000269270. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : 2D ARRAY REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : MEMBRANE-BOUND O REMARK 245 -ACYLTRANSFERASE 7 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 6.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : PURIFIED PROTEIN REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2200.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : OTHER REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5550.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 442 REMARK 465 LEU A 443 REMARK 465 GLY A 444 REMARK 465 LEU A 445 REMARK 465 ALA A 446 REMARK 465 LEU A 447 REMARK 465 GLY A 448 REMARK 465 GLY A 449 REMARK 465 GLY A 450 REMARK 465 SER A 451 REMARK 465 PRO A 452 REMARK 465 SER A 453 REMARK 465 ARG A 454 REMARK 465 ARG A 455 REMARK 465 LYS A 456 REMARK 465 ALA A 457 REMARK 465 ALA A 458 REMARK 465 SER A 459 REMARK 465 GLN A 460 REMARK 465 PRO A 461 REMARK 465 THR A 462 REMARK 465 SER A 463 REMARK 465 LEU A 464 REMARK 465 ALA A 465 REMARK 465 PRO A 466 REMARK 465 GLU A 467 REMARK 465 LYS A 468 REMARK 465 LEU A 469 REMARK 465 ARG A 470 REMARK 465 GLU A 471 REMARK 465 GLU A 472 REMARK 465 LEU A 473 REMARK 465 GLU A 474 REMARK 465 ALA A 475 REMARK 465 CYS A 476 REMARK 465 GLY A 477 REMARK 465 ILE A 478 REMARK 465 GLU A 479 REMARK 465 ASN A 480 REMARK 465 LEU A 481 REMARK 465 TYR A 482 REMARK 465 PHE A 483 REMARK 465 GLN A 484 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 246 OG1 THR A 307 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 181 70.97 52.78 REMARK 500 VAL A 311 -65.77 -102.80 REMARK 500 ILE A 332 -51.47 -122.52 REMARK 500 LEU A 417 -4.22 67.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-28552 RELATED DB: EMDB REMARK 900 HUMAN MEMBRANE-BOUND O-ACYLTRANSFERASE 7 DBREF 8ERC A 1 472 UNP Q96N66 MBOA7_HUMAN 1 472 SEQADV 8ERC LEU A 473 UNP Q96N66 EXPRESSION TAG SEQADV 8ERC GLU A 474 UNP Q96N66 EXPRESSION TAG SEQADV 8ERC ALA A 475 UNP Q96N66 EXPRESSION TAG SEQADV 8ERC CYS A 476 UNP Q96N66 EXPRESSION TAG SEQADV 8ERC GLY A 477 UNP Q96N66 EXPRESSION TAG SEQADV 8ERC ILE A 478 UNP Q96N66 EXPRESSION TAG SEQADV 8ERC GLU A 479 UNP Q96N66 EXPRESSION TAG SEQADV 8ERC ASN A 480 UNP Q96N66 EXPRESSION TAG SEQADV 8ERC LEU A 481 UNP Q96N66 EXPRESSION TAG SEQADV 8ERC TYR A 482 UNP Q96N66 EXPRESSION TAG SEQADV 8ERC PHE A 483 UNP Q96N66 EXPRESSION TAG SEQADV 8ERC GLN A 484 UNP Q96N66 EXPRESSION TAG SEQRES 1 A 484 MET SER PRO GLU GLU TRP THR TYR LEU VAL VAL LEU LEU SEQRES 2 A 484 ILE SER ILE PRO ILE GLY PHE LEU PHE LYS LYS ALA GLY SEQRES 3 A 484 PRO GLY LEU LYS ARG TRP GLY ALA ALA ALA VAL GLY LEU SEQRES 4 A 484 GLY LEU THR LEU PHE THR CYS GLY PRO HIS THR LEU HIS SEQRES 5 A 484 SER LEU VAL THR ILE LEU GLY THR TRP ALA LEU ILE GLN SEQRES 6 A 484 ALA GLN PRO CYS SER CYS HIS ALA LEU ALA LEU ALA TRP SEQRES 7 A 484 THR PHE SER TYR LEU LEU PHE PHE ARG ALA LEU SER LEU SEQRES 8 A 484 LEU GLY LEU PRO THR PRO THR PRO PHE THR ASN ALA VAL SEQRES 9 A 484 GLN LEU LEU LEU THR LEU LYS LEU VAL SER LEU ALA SER SEQRES 10 A 484 GLU VAL GLN ASP LEU HIS LEU ALA GLN ARG LYS GLU MET SEQRES 11 A 484 ALA SER GLY PHE SER LYS GLY PRO THR LEU GLY LEU LEU SEQRES 12 A 484 PRO ASP VAL PRO SER LEU MET GLU THR LEU SER TYR SER SEQRES 13 A 484 TYR CYS TYR VAL GLY ILE MET THR GLY PRO PHE PHE ARG SEQRES 14 A 484 TYR ARG THR TYR LEU ASP TRP LEU GLU GLN PRO PHE PRO SEQRES 15 A 484 GLY ALA VAL PRO SER LEU ARG PRO LEU LEU ARG ARG ALA SEQRES 16 A 484 TRP PRO ALA PRO LEU PHE GLY LEU LEU PHE LEU LEU SER SEQRES 17 A 484 SER HIS LEU PHE PRO LEU GLU ALA VAL ARG GLU ASP ALA SEQRES 18 A 484 PHE TYR ALA ARG PRO LEU PRO ALA ARG LEU PHE TYR MET SEQRES 19 A 484 ILE PRO VAL PHE PHE ALA PHE ARG MET ARG PHE TYR VAL SEQRES 20 A 484 ALA TRP ILE ALA ALA GLU CYS GLY CYS ILE ALA ALA GLY SEQRES 21 A 484 PHE GLY ALA TYR PRO VAL ALA ALA LYS ALA ARG ALA GLY SEQRES 22 A 484 GLY GLY PRO THR LEU GLN CYS PRO PRO PRO SER SER PRO SEQRES 23 A 484 GLU LYS ALA ALA SER LEU GLU TYR ASP TYR GLU THR ILE SEQRES 24 A 484 ARG ASN ILE ASP CYS TYR SER THR ASP PHE CYS VAL ARG SEQRES 25 A 484 VAL ARG ASP GLY MET ARG TYR TRP ASN MET THR VAL GLN SEQRES 26 A 484 TRP TRP LEU ALA GLN TYR ILE TYR LYS SER ALA PRO ALA SEQRES 27 A 484 ARG SER TYR VAL LEU ARG SER ALA TRP THR MET LEU LEU SEQRES 28 A 484 SER ALA TYR TRP HIS GLY LEU HIS PRO GLY TYR TYR LEU SEQRES 29 A 484 SER PHE LEU THR ILE PRO LEU CYS LEU ALA ALA GLU GLY SEQRES 30 A 484 ARG LEU GLU SER ALA LEU ARG GLY ARG LEU SER PRO GLY SEQRES 31 A 484 GLY GLN LYS ALA TRP ASP TRP VAL HIS TRP PHE LEU LYS SEQRES 32 A 484 MET ARG ALA TYR ASP TYR MET CYS MET GLY PHE VAL LEU SEQRES 33 A 484 LEU SER LEU ALA ASP THR LEU ARG TYR TRP ALA SER ILE SEQRES 34 A 484 TYR PHE CYS ILE HIS PHE LEU ALA LEU ALA ALA LEU GLY SEQRES 35 A 484 LEU GLY LEU ALA LEU GLY GLY GLY SER PRO SER ARG ARG SEQRES 36 A 484 LYS ALA ALA SER GLN PRO THR SER LEU ALA PRO GLU LYS SEQRES 37 A 484 LEU ARG GLU GLU LEU GLU ALA CYS GLY ILE GLU ASN LEU SEQRES 38 A 484 TYR PHE GLN HELIX 1 AA1 SER A 2 LYS A 24 1 23 HELIX 2 AA2 GLY A 26 GLY A 47 1 22 HELIX 3 AA3 HIS A 49 GLN A 67 1 19 HELIX 4 AA4 SER A 70 ALA A 88 1 19 HELIX 5 AA5 ALA A 88 GLY A 93 1 6 HELIX 6 AA6 THR A 98 GLY A 133 1 36 HELIX 7 AA7 SER A 148 TYR A 157 1 10 HELIX 8 AA8 ARG A 169 GLU A 178 1 10 HELIX 9 AA9 SER A 187 TRP A 196 1 10 HELIX 10 AB1 PRO A 197 PHE A 212 1 16 HELIX 11 AB2 PRO A 213 ARG A 225 5 13 HELIX 12 AB3 PRO A 226 ALA A 259 1 34 HELIX 13 AB4 ALA A 267 LYS A 269 5 3 HELIX 14 AB5 SER A 285 LEU A 292 1 8 HELIX 15 AB6 ASP A 303 PHE A 309 1 7 HELIX 16 AB7 ARG A 312 TYR A 319 1 8 HELIX 17 AB8 ASN A 321 ILE A 332 1 12 HELIX 18 AB9 SER A 340 GLY A 357 1 18 HELIX 19 AC1 HIS A 359 ARG A 384 1 26 HELIX 20 AC2 SER A 388 LEU A 417 1 30 HELIX 21 AC3 SER A 418 ILE A 429 1 12 HELIX 22 AC4 PHE A 431 LEU A 441 1 11 SHEET 1 AA1 2 TYR A 264 PRO A 265 0 SHEET 2 AA1 2 TYR A 294 ASP A 295 -1 O ASP A 295 N TYR A 264 CISPEP 1 GLY A 165 PRO A 166 0 -3.06 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000